- Release Date: 21/12/20 09:02
- Summary: 57% Cholesterol Reduction from NYX-PCSK9i In Vivo Study
- Price Sensitive: Yes
- Download Document 307.97KB
- Forums
- ASX - By Stock
- Ann: 57% Cholesterol Reduction from NYX-PCSK9i In Vivo Study
NYR
nyrada inc.
Add to My Watchlist
5.66%
!
25.0¢

Ann: 57% Cholesterol Reduction from NYX-PCSK9i In Vivo Study
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
25.0¢ |
Change
-0.015(5.66%) |
Mkt cap ! $59.72M |
Open | High | Low | Value | Volume |
27.0¢ | 27.0¢ | 25.0¢ | $101.9K | 385.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 75847 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.5¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 75847 | 0.250 |
2 | 83000 | 0.245 |
3 | 33166 | 0.240 |
1 | 10000 | 0.235 |
3 | 126521 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.255 | 20000 | 1 |
0.260 | 50000 | 1 |
0.275 | 172700 | 2 |
0.280 | 71228 | 1 |
0.285 | 2360 | 1 |
Last trade - 16.10pm 15/09/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman and CEO
Hank Holland
Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online